| Patient | Wilma Rudolph |
|---|---|
| Date of birth | 1972-06-23 |
| Identifiers | MRN HR-ML036-SYN; SSN (made up) 000-36-5170 |
| Document date | 2026-07-02 |
| Author | Gloria Haynes-Whitaker, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
MRI result and neuro-oncology consultation. [S]
Ms. Rudolph returns three days after her first visit. The MRI the next morning showed a 3.8 cm ring-enhancing mass in the left posterior frontal lobe with central necrosis, surrounding edema and 5 mm of midline shift. Dr. Haynes-Whitaker telephoned her the same afternoon and started dexamethasone 4 mg twice a day with famotidine. Since then the morning headaches have eased and her words come more easily, though she still pauses now and then; the right hand is a little steadier. CT of the chest, abdomen and pelvis yesterday showed no cancer elsewhere. She has had no seizure, vomiting or drowsiness. She saw Dr. Brzezinski of neuro-oncology this morning, together with the neurosurgery team. She is not driving. She said that as a child she was told she would never walk, and that she wants the facts as they are. She has had no thoughts of self-harm. [S]
| Element | Detail |
|---|---|
| MRI | 3.8 cm ring-enhancing left posterior frontal mass with necrosis, edema and 5 mm midline shift; raised perfusion; no other lesion |
| CT body | No primary cancer elsewhere |
| Dexamethasone | 4 mg twice a day for two days; headache and speech better |
| Coordination | Neuro-oncology and neurosurgery seen today; awake craniotomy planned in six days |
| Her questions | What the mass is, whether surgery can take it out without harming her speech or hand, and what comes after |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No fever, night sweats or weight loss |
| Neurological | Positive | Occasional word-finding pauses, improving; right hand slightly clumsy; headache much less; no seizure |
| Eyes | Negative | No double vision |
| Gastrointestinal | Negative | No nausea, vomiting or heartburn |
| Endocrine | Negative | No thirst or frequent urination |
| Psychiatric | Positive | Worried and sleeping poorly since the call; PHQ-9 7 and GAD-7 9; no thoughts of self-harm |
6 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Acetaminophen 500 mg oral tablet, two tablets by mouth every 6 hours as needed for headache, no more than 3 g a day | Two tablets every 6 hours as needed | Oral route | 2026-06-29 | active | S |
| Dexamethasone 4 mg oral tablet, one tablet twice a day with food, for symptomatic vasogenic edema, until surgery | One tablet twice a day with breakfast and lunch | Oral route | 2026-06-30 to 2026-07-08 | completed | S |
| Famotidine 20 mg oral tablet, one tablet twice a day while taking dexamethasone | One tablet twice a day | Oral route | 2026-06-30 to 2026-08-12 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-07-02 | Body height | 180 | cm | S |
| 2026-07-02 | Body weight | 67.8 | kg | S |
| 2026-07-02 | Body mass index (BMI) [Ratio] | 20.9 | kg/m2 | S |
| 2026-07-02 | Systolic blood pressure | 134 | mm[Hg] | S |
| 2026-07-02 | Diastolic blood pressure | 82 | mm[Hg] | S |
| 2026-07-02 | Heart rate | 78 | /min | S |
| 2026-07-02 | Respiratory rate | 14 | /min | S |
| 2026-07-02 | Body temperature | 36.6 | Cel | S |
| 2026-07-02 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-07-02 | Hemoglobin [Mass/volume] in Blood | 13 | g/dL | 12-15.5 g/dL | Normal | S |
| 2026-07-02 | Leukocytes [#/volume] in Blood by Automated count | 11.8 | 10*3/uL | 4-11 10*3/uL | High | S |
| 2026-07-02 | Platelets [#/volume] in Blood by Automated count | 270 | 10*3/uL | 150-400 10*3/uL | Normal | S |
| 2026-07-02 | Sodium [Moles/volume] in Serum or Plasma | 140 | mmol/L | 135-145 mmol/L | Normal | S |
| 2026-07-02 | Potassium [Moles/volume] in Serum or Plasma | 4 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-07-02 | Creatinine [Mass/volume] in Serum or Plasma | 0.84 | mg/dL | 0.59-1.04 mg/dL | Normal | S |
| 2026-07-02 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 83 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-07-02 | Glucose [Mass/volume] in Serum or Plasma | 138 | mg/dL | 70-99 mg/dL | High | S |
| 2026-07-02 | INR in Platelet poor plasma by Coagulation assay | 1 | {INR} | 0.9-1.1 | Normal | S |
| 2026-07-02 | aPTT in Blood by Coagulation assay | 29 | s | 25-37 s | Normal | S |
| 2026-07-02 | Karnofsky Performance Status score | 80 | {score} | S | ||
| 2026-07-02 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 7 | {score} | S | ||
| 2026-07-02 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 9 | {score} | S |
Vital signs recorded on 2026-07-02; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well; weight 67.8 kg; blood pressure 134/82, pulse 78 |
| Mental status and speech | Alert and oriented; fluent with rare word-finding pauses; naming 15 of 15; repetition and comprehension intact |
| Cranial nerves | Mild flattening of the right nasolabial fold; fundi without papilledema |
| Motor | Slight right pronator drift; right grip and finger extension 4+/5; legs 5/5 on both sides |
| Gait | Steady, normal stride; tandem gait slightly unsteady |
| Extremities | Left calf slightly smaller than the right, from childhood polio; no leg swelling |
| Psychiatric | Composed and direct; anxious when talking about her speech |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Three weeks of headaches on waking, with ten days of pauses in finding words and clumsiness of the right hand, in a previously well woman of 54: an intracranial lesion must be excluded. MRI of the brain with and without contrast booked for tomorrow morning, and neuro-oncology review booked | resolved | confirmed | R29.818 | S — Synthetic presenting problem; no symptom of her real illness was made public. Superseded when the MRI showed a brain mass. |
| Left posterior frontal ring-enhancing mass, 3.8 cm, with central necrosis, surrounding edema and 5 mm midline shift, next to the language and motor areas; presumed high-grade glioma, with no primary cancer elsewhere on CT; tissue diagnosis pending | active | confirmed | D49.6 | S — Synthetic imaging diagnosis before surgery; superseded by the pathology. |
| Late effects of childhood poliomyelitis: paralysis of the left leg in early childhood, treated with a metal brace, a special shoe, massage and heat, with full recovery of walking by about age 12 and a later career as an Olympic sprinter; no new weakness, fatigue or pain now to suggest post-polio syndrome | active | confirmed | B91 | S — Documented childhood polio (D); the current absence of new symptoms is synthetic. |
| Vasogenic cerebral edema around the left frontal mass, with 5 mm midline shift, causing headache and contributing to the language and right-hand symptoms; treated with dexamethasone | active | confirmed | G93.6 | S — Synthetic finding on the first MRI. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Imaging | MRI of the brain with and without contrast | At once for new progressive focal symptoms | Up to date | The morning after the first visit: ring-enhancing left frontal mass with necrosis, edema and midline shift |
| Imaging | Advanced MRI sequences (diffusion and perfusion) | With the diagnostic MRI | Up to date | No restricted diffusion in the necrotic center (abscess unlikely); raised relative cerebral blood volume in the rim (high-grade tumor likely) |
| Imaging | CT of the chest, abdomen and pelvis | When a metastasis is possible | Up to date | Yesterday: no primary cancer elsewhere |
| Imaging | Functional MRI with tractography | Before surgery near language or motor areas | Ordered | In four days |
| Examination | Neurologic examination (language, strength, gait) | Each visit | Completed today | Rare word-finding pauses; slight right pronator drift; right grip 4+/5; better than at the first visit |
| Survey | Performance status (Karnofsky) | Each visit | Completed today | Karnofsky 80 |
| Medication safety | Dexamethasone: indication, dose and effects | When started and at each visit | Completed today | Started for edema causing symptoms at 4 mg twice a day; glucose 138 mg/dL and white cells 11.8 on the steroid; famotidine for stomach protection; taper after surgery |
| Laboratory | Preoperative blood count, chemistry and clotting | Within 30 days before surgery | Completed today | Hemoglobin 13.0 g/dL, platelets 270; sodium 140, potassium 4.0, creatinine 0.84 mg/dL, eGFR 83; INR 1.0, aPTT 29 seconds |
| Medication safety | Seizure history and antiseizure drug need | At diagnosis and each visit | Not indicated | No seizure has occurred, so no prophylactic antiseizure drug, as the SNO-EANO guideline advises |
| Examination | Signs of leg clot or pulmonary embolism | Each visit; brain tumors carry a high thrombosis risk | Completed today | No leg swelling or breathlessness; hospital prophylaxis after surgery planned |
| Referral | Neuro-oncology and neurosurgery | Within a week of an MRI showing a probable brain tumor | Completed today | Seen this morning; recommendations in the consultation note |
| Survey | Distress and depression screen (PHQ-9) | At diagnosis, each treatment phase, and when symptoms change | Completed today | PHQ-9 7 and GAD-7 9, mild, with worry about the diagnosis; no thoughts of self-harm |
| Self-management | Driving | From the first focal symptom | Completed today | Not driving; reviewed again after surgery and treatment |
| Self-management | Falls, leg strength and late effects of polio | Each visit | Completed today | No falls; legs strong; uses the handrail on stairs while the right hand is weak |
Goal progress:
Guideline basis: NCCN Clinical Practice Guidelines in Oncology: Central Nervous System Cancers (2026); Weller M, et al. EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood. Nat Rev Clin Oncol 2021;18(3):170-186 (PMID 33293629) (2021); Louis DN, et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol 2021;23(8):1231-1251 (PMID 34185076) (2021); Walbert T, et al. SNO and EANO practice guideline update: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Neuro Oncol 2021;23(11):1835-1844 (PMID 34174071) (2021); Key NS, et al. Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Guideline Update. J Clin Oncol 2023;41(16):3063-3071 (PMID 37075273) (2023); Farbu E, et al. EFNS guideline on diagnosis and management of post-polio syndrome. Eur J Neurol 2006;13(8):795-801 (PMID 16879288) (2006); CMID: Clinical Monitoring Intelligence Database, depression monograph (2026); Depression and Suicide Risk in Adults: Screening (2023)
Follow-up: Functional MRI in four days and surgery in six. Primary care review about three weeks after surgery with the pathology. Go to the emergency department for a seizure, worsening speech or weakness, vomiting or drowsiness. Next scheduled visit 2026-07-29: review three weeks after awake craniotomy: pathology and molecular diagnosis, steroid taper, steroid-related hyperglycemia, falls, and the plan for radiotherapy with temozolomide. [S]